Tower Research Capital (TRC)’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$694K Buy
8,304
+2,262
+37% +$186K 0.02% 715
2025
Q4
$554K Buy
6,042
+569
+10% +$54.5K 0.01% 776
2025
Q3
$519K Sell
5,473
-8,648
-61% -$814K 0.01% 831
2025
Q2
$1.48M Buy
14,121
+9,742
+222% +$923K 0.04% 391
2025
Q1
$387K Sell
4,379
-3,868
-47% -$397K 0.01% 993
2024
Q4
$791K Buy
8,247
+4,237
+106% +$395K 0.02% 759
2024
Q3
$328K Sell
4,010
-11,605
-74% -$895K 0.01% 1178
2024
Q2
$1.35M Buy
15,615
+12,523
+405% +$1.01M 0.02% 584
2024
Q1
$252K Sell
3,092
-9,023
-74% -$705K 0.01% 1269
2023
Q4
$803K Buy
12,115
+6,607
+120% +$458K 0.01% 1013
2023
Q3
$402K Sell
5,508
-689
-11% -$46.5K 0.01% 999
2023
Q2
$391K Buy
6,197
+1,404
+29% +$81.4K 0.01% 1134
2023
Q1
$281K Buy
4,793
+990
+26% +$60.1K 0.01% 1174
2022
Q4
$234K Sell
3,803
-5,490
-59% -$369K 0.01% 1206
2022
Q3
$624K Buy
9,293
+3,160
+52% +$200K 0.01% 973
2022
Q2
$376K Buy
6,133
+3,135
+105% +$201K 0.01% 1314
2022
Q1
$202K Sell
2,998
-2,971
-50% -$160K ﹤0.01% 1718
2021
Q4
$264K Buy
5,969
+1,273
+27% +$74.1K ﹤0.01% 1557
2021
Q3
$304K Sell
4,696
-4,092
-47% -$284K 0.01% 1393
2021
Q2
$707K Sell
8,788
-2,196
-20% -$167K 0.02% 915
2021
Q1
$747K Buy
10,984
+5,011
+84% +$394K 0.01% 934
2020
Q4
$416K Sell
5,973
-69,457
-92% -$4.32M 0.01% 1135
2020
Q3
$3.87M Buy
75,430
+52,432
+228% +$2.88M 0.04% 123
2020
Q2
$1.35M Buy
+22,998
New +$1.27M 0.06% 365
2020
Q1
Sell
-4,050
Closed -$300K 3416
2019
Q4
$300K Buy
4,050
+2,513
+164% +$157K 0.02% 444
2019
Q3
$88K Buy
1,537
+493
+47% +$32.7K 0.01% 1432
2019
Q2
$68K Buy
1,044
+619
+146% +$43.1K ﹤0.01% 1407
2019
Q1
$31K Buy
+425
New +$29.9K ﹤0.01% 2015
2018
Q4
Sell
-4,670
Closed -$441K 4039
2018
Q3
$441K Buy
4,670
+2,229
+91% +$192K 0.03% 550
2018
Q2
$183K Sell
2,441
-4,963
-67% -$356K 0.01% 1108
2018
Q1
$448K Buy
+7,404
New +$401K 0.04% 528
2017
Q4
Sell
-3,729
Closed -$189K 3722
2017
Q3
$189K Buy
+3,729
New +$174K 0.02% 805
2017
Q2
Sell
-168
Closed -$7K 3023
2017
Q1
$7K Sell
168
-665
-80% -$29.4K ﹤0.01% 1997
2016
Q4
$34K Buy
+833
New +$32.2K ﹤0.01% 1689
2016
Q2
Sell
-465
Closed -$11K 4651
2016
Q1
$11K Sell
465
-237
-34% -$5.08K ﹤0.01% 1859
2015
Q4
$18K Sell
702
-616
-47% -$18.9K ﹤0.01% 1404
2015
Q3
$39K Buy
+1,318
New +$41.4K ﹤0.01% 1193
2015
Q2
Sell
-190
Closed -$5K 4652
2015
Q1
$5K Sell
190
-26
-12% -$564 ﹤0.01% 3239
2014
Q4
$5K Buy
+216
New +$4.69K ﹤0.01% 2715

Other funds holding HQY

Tower Research Capital (TRC)'s HQY Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its HealthEquity (HQY) stake by 37% in Q1 2026, buying an estimated $186K and bringing the position to 8,304 shares worth $694K. The position accounts for 0.02% of the portfolio, ranked #715.

Tower Research Capital (TRC) first reported a position in HQY in Q4 2014 and has held it in 39 quarters since. The position peaked at $3.87M in Q3 2020. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Tower Research Capital (TRC) held 8,304 shares of HealthEquity worth $694K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,262 HealthEquity shares in Q1 2026, an estimated $186K.
  • HealthEquity made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #715 holding.
  • Tower Research Capital (TRC) first reported a position in HealthEquity in Q4 2014 and has held it in 39 quarters since.
  • Tower Research Capital (TRC)'s HealthEquity position peaked at $3.87M in Q3 2020.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.